Jain, Manu http://orcid.org/0000-0003-1534-5629
Budinger, GRS
Jovanovic, Borko
Dematte, Jane
Duffey, Sara
Mehta, Jayesh
Article History
Received: 30 June 2017
Revised: 22 December 2017
Accepted: 24 January 2018
First Online: 9 March 2018
Compliance with ethical standards
:
: JM reports having received honoraria from Millennium Pharmaceuticals, the manufacturer of bortezomib, for speaking on the use of bortezomib in myeloma. The remaining authors declare that they have no conflict of interest.